AirSculpt Technologies (AIRS) Competitors

CareDx (NASDAQ:CDNA) and AirSculpt Technologies (NASDAQ:AIRS) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, dividends, risk, earnings, analyst recommendations, valuation, media sentiment and institutional ownership.

Is CDNA or AIRS more profitable?

CareDx has a net margin of 19.79% compared to AirSculpt Technologies' net margin of -9.95%. CareDx's return on equity of 21.16% beat AirSculpt Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CareDx	19.79%	21.16%	14.25%
AirSculpt Technologies	-9.95%	-15.01%	-5.85%

Do insiders & institutionals hold more shares of CDNA or AIRS?

91.5% of AirSculpt Technologies shares are held by institutional investors. 4.4% of CareDx shares are held by insiders. Comparatively, 76.6% of AirSculpt Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Which has more risk & volatility, CDNA or AIRS?

CareDx has a beta of 2.19, meaning that its stock price is 119% more volatile than the S&P 500. Comparatively, AirSculpt Technologies has a beta of 2.46, meaning that its stock price is 146% more volatile than the S&P 500.

Which has better valuation & earnings, CDNA or AIRS?

CareDx has higher revenue and earnings than AirSculpt Technologies. AirSculpt Technologies is trading at a lower price-to-earnings ratio than CareDx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CareDx	$333.79M	3.20	$52.55M	$1.15	16.69
AirSculpt Technologies	$172.10M	1.83	-$8.25M	-$0.30	-17.82

Does the media refer more to CDNA or AIRS?

In the previous week, CareDx had 4 more articles in the media than AirSculpt Technologies. MarketBeat recorded 5 mentions for CareDx and 1 mentions for AirSculpt Technologies. AirSculpt Technologies' average media sentiment score of 1.00 beat CareDx's score of 0.92 indicating that AirSculpt Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CareDx	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AirSculpt Technologies	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts recommend CDNA or AIRS?

CareDx currently has a consensus target price of $30.33, indicating a potential upside of 58.03%. AirSculpt Technologies has a consensus target price of $3.75, indicating a potential downside of 29.84%. Given CareDx's stronger consensus rating and higher possible upside, research analysts plainly believe CareDx is more favorable than AirSculpt Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CareDx	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67
AirSculpt Technologies	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

CareDx beats AirSculpt Technologies on 12 of the 16 factors compared between the two stocks.